secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIZYME, INC. (—)
CIK:        0001413754
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001493152-26-017470
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marizyme transfers all assets via assignment for benefit of creditors; files under Florida Chapter 727
--------------------------------------------------------------------------------

- Company entered Assignment for Benefit of Creditors on April 14, 2026, transferring all assets to Assignee Peter Hurwitz.
- Company is unable to pay debts as they become due; intends to file under Florida Chapter 727 by April 17, 2026.
- Assignee will liquidate assets and distribute proceeds to creditors pro rata in accordance with Florida Statutes § 727.114.
- Board determined transfer of all or substantially all assets was in best interests; CEO David Barthel authorized the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413754/000149315226017470/0001493152-26-017470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413754/000149315226017470/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-017470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer